Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for VORICONAZOLE FOR INJECTION

Brand name

VORICONAZOLE FOR INJECTION

Company Name

SANDOZ CANADA INCORPORATED

Drug Identification Number

02381966

Ingredients & Strength

VORICONAZOLE (200 MG)

Anatomical Therapeutical Chemical (ATC) Code

J02AC

Anatomical Therapeutical Chemical (ATC) Descriptor

ANTIMYCOTICS FOR SYSTEMIC USE

Status

MARKETED

Shortage reports
Brand name	Packaging size	Status	Date Created	Date Updated	Reports
VORICONAZOLE FOR INJECTION	1 vial	Resolved	2019-04-10	2019-07-24	80984
VORICONAZOLE FOR INJECTION	1LYVI	Actual shortage	2026-02-09	2026-02-16	277665

1

Showing 1 to 2 of 2

Discontinuation reports
Brand name	Packaging size	Status	Date Created	Date Updated	Reports

1

Showing 1 to 0 of 0

Reports for VORICONAZOLE FOR INJECTION

Brand name VORICONAZOLE FOR INJECTION

Brand name

VORICONAZOLE FOR INJECTION